Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Loomer

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Personalized Medicine|November 16, 2017
Access to Guideline-Recommended Pharmacogenomic Tests for Cancer Treatments: Experience of Providers and PatientsAnn Chen Wu, Kathleen M Mazor, Rachel Ceccarelli, et al.
Journal of Personalized Medicine|October 3, 2018
The Implementation Process for Pharmacogenomic Testing for Cancer-Targeted TherapiesAnn Chen Wu, Kathleen M Mazor, Rachel Ceccarelli, et al.
International Journal of Bipolar Disorders|February 18, 2026
Views on an antipsychotic regimen administered once every 2 months: a qualitative interview study of people living with bipolar I disorder, caregivers, and prescribers in the USA and CanadaMauricio Tohen, Murat Yildirim, Stephanie Loomer, et al.
Current Medical Research and Opinion|January 17, 2025
Drivers and barriers to health-seeking behaviors and interactions: a qualitative study of Black patients with lung cancer and with peripheral artery diseaseLisa Dwyer Orr, Kay Sadik, Kathleen Beusterien, et al.
Current Medical Research and Opinion|November 21, 2025
Understanding patient, caregiver, and prescriber preferences for an antipsychotic regimen administered once every 2 months for schizophrenia or bipolar I disorder: a qualitative interview study in North AmericaRoger S McIntyre, Murat Yildirim, Stephanie Loomer, et al.
Journal of Personalized Medicine|May 19, 2018
Insurance Coverage Policies for Pharmacogenomic and Multi-Gene Testing for CancerChristine Y Lu, Stephanie Loomer, Rachel Ceccarelli, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
HSR25-193: Characterizing Influences to Multidisciplinary Team Care in Resectable Non-Small Cell Lung Cancer: A Qualitative StudyDaniel Simmons, Emily Mulvihill, Nicole Kashine, et al.
Patient Preference and Adherence|May 5, 2025
Exploring Patient, Caregiver, and Prescriber Preferences for an Injectable Antipsychotic Administered Every 2 Months for the Maintenance Treatment of Schizophrenia: A Multicenter Qualitative Interview Study Conducted in EuropeSofia Pappa, Murat Yildirim, Stephanie Loomer, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Personalized Medicine|November 16, 2017
Access to Guideline-Recommended Pharmacogenomic Tests for Cancer Treatments: Experience of Providers and PatientsAnn Chen Wu, Kathleen M Mazor, Rachel Ceccarelli, et al.
Journal of Personalized Medicine|October 3, 2018
The Implementation Process for Pharmacogenomic Testing for Cancer-Targeted TherapiesAnn Chen Wu, Kathleen M Mazor, Rachel Ceccarelli, et al.
International Journal of Bipolar Disorders|February 18, 2026
Views on an antipsychotic regimen administered once every 2 months: a qualitative interview study of people living with bipolar I disorder, caregivers, and prescribers in the USA and CanadaMauricio Tohen, Murat Yildirim, Stephanie Loomer, et al.
Current Medical Research and Opinion|January 17, 2025
Drivers and barriers to health-seeking behaviors and interactions: a qualitative study of Black patients with lung cancer and with peripheral artery diseaseLisa Dwyer Orr, Kay Sadik, Kathleen Beusterien, et al.
Current Medical Research and Opinion|November 21, 2025
Understanding patient, caregiver, and prescriber preferences for an antipsychotic regimen administered once every 2 months for schizophrenia or bipolar I disorder: a qualitative interview study in North AmericaRoger S McIntyre, Murat Yildirim, Stephanie Loomer, et al.
Journal of Personalized Medicine|May 19, 2018
Insurance Coverage Policies for Pharmacogenomic and Multi-Gene Testing for CancerChristine Y Lu, Stephanie Loomer, Rachel Ceccarelli, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
HSR25-193: Characterizing Influences to Multidisciplinary Team Care in Resectable Non-Small Cell Lung Cancer: A Qualitative StudyDaniel Simmons, Emily Mulvihill, Nicole Kashine, et al.
Patient Preference and Adherence|May 5, 2025
Exploring Patient, Caregiver, and Prescriber Preferences for an Injectable Antipsychotic Administered Every 2 Months for the Maintenance Treatment of Schizophrenia: A Multicenter Qualitative Interview Study Conducted in EuropeSofia Pappa, Murat Yildirim, Stephanie Loomer, et al.
Pageof 1